The low percentage of drug-resistant PSA-producing cancer cell population of 6.36 x 10−2% combined with the slow growth rate of the drug-resistant PSA-producing cancer cell population of 3.53 x 10−4 day-1 contributed to the sustained PSA decline in this subject (Fig 4A). The gene discussed is KLK3; the disease is cancer.